Exome Asset Management LLC Gossamer Bio, Inc. Transaction History
Exome Asset Management LLC
- $135 Billion
- Q2 2025
A detailed history of Exome Asset Management LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 1,097,999 shares of GOSS stock, worth $2.53 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
1,097,999
Previous 1,097,999
-0.0%
Holding current value
$2.53 Million
Previous $1.35 Billion
-0.0%
% of portfolio
1.0%
Previous 1.0%
Shares
3 transactions
Others Institutions Holding GOSS
# of Institutions
148Shares Held
161MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$42.2 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.6 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$26.2 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.4 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $216M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...